MOXIFLOXACIN

N/A

Manufactured by Lifestar Pharma LLC

40,887 FDA adverse event reports analyzed

Last updated: 2026-04-14

About MOXIFLOXACIN

MOXIFLOXACIN is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Lifestar Pharma LLC. The most commonly reported adverse reactions for MOXIFLOXACIN include OFF LABEL USE, DRUG INEFFECTIVE, DYSPNOEA, PNEUMONIA, VOMITING. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for MOXIFLOXACIN.

Top Adverse Reactions

OFF LABEL USE1,369 reports
DRUG INEFFECTIVE1,347 reports
DYSPNOEA1,226 reports
PNEUMONIA1,142 reports
VOMITING1,101 reports
DRUG HYPERSENSITIVITY1,073 reports
ASTHMA910 reports
PAIN832 reports
NAUSEA814 reports
WHEEZING795 reports
RASH757 reports
CONDITION AGGRAVATED750 reports
FATIGUE735 reports
DIARRHOEA715 reports
PYREXIA682 reports
MALAISE669 reports
OEDEMA601 reports
EYE PAIN588 reports
DRUG INTOLERANCE587 reports
HEADACHE576 reports
NEUROPATHY PERIPHERAL568 reports
COUGH539 reports
ANXIETY522 reports
PRODUCT USE IN UNAPPROVED INDICATION515 reports
DIZZINESS503 reports
ARTHRALGIA496 reports
HYPERSENSITIVITY491 reports
HYPERTENSION458 reports
TREATMENT FAILURE439 reports
CHEST PAIN435 reports
ASTHENIA416 reports
ELECTROCARDIOGRAM QT PROLONGED414 reports
DRUG RESISTANCE408 reports
JOINT SWELLING403 reports
PRURITUS394 reports
DRUG INTERACTION357 reports
RHEUMATOID ARTHRITIS354 reports
HEPATIC ENZYME INCREASED351 reports
THROMBOCYTOPENIA348 reports
DEATH347 reports
LUNG DISORDER341 reports
ABDOMINAL PAIN UPPER336 reports
URTICARIA336 reports
DECREASED APPETITE335 reports
PAIN IN EXTREMITY335 reports
GASTROINTESTINAL DISORDER312 reports
INFUSION RELATED REACTION312 reports
SINUSITIS309 reports
INFECTION306 reports
PRODUCTIVE COUGH305 reports
ABDOMINAL PAIN301 reports
NASOPHARYNGITIS299 reports
ABDOMINAL DISCOMFORT293 reports
ACUTE KIDNEY INJURY291 reports
PARAESTHESIA285 reports
HYPOAESTHESIA282 reports
PRODUCT USE ISSUE277 reports
VISION BLURRED275 reports
ANAEMIA273 reports
WEIGHT DECREASED272 reports
DEPRESSION270 reports
PULMONARY EMBOLISM267 reports
CONFUSIONAL STATE260 reports
LOWER RESPIRATORY TRACT INFECTION259 reports
STOMATITIS258 reports
WEIGHT INCREASED257 reports
THERAPEUTIC PRODUCT EFFECT INCOMPLETE251 reports
SWELLING244 reports
GENERAL PHYSICAL HEALTH DETERIORATION241 reports
UPPER RESPIRATORY TRACT INFECTION238 reports
PERIPHERAL SWELLING234 reports
CONTRAINDICATED PRODUCT ADMINISTERED233 reports
HYPOXIA230 reports
PRODUCT DOSE OMISSION ISSUE229 reports
EYE IRRITATION225 reports
FIBROMYALGIA225 reports
LIVER DISORDER223 reports
ALOPECIA221 reports
INTENTIONAL PRODUCT USE ISSUE220 reports
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION220 reports
MUSCLE SPASMS218 reports
RESPIRATORY TRACT INFECTION213 reports
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS212 reports
MUSCULOSKELETAL PAIN210 reports
OEDEMA PERIPHERAL209 reports
VISUAL IMPAIRMENT208 reports
MUSCULOSKELETAL STIFFNESS207 reports
BRONCHITIS205 reports
PSORIASIS204 reports
HEPATOTOXICITY201 reports
MOBILITY DECREASED200 reports
HAEMOPTYSIS191 reports
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES190 reports
INFLAMMATION189 reports
MIGRAINE189 reports
HYPERHIDROSIS188 reports
OBSTRUCTIVE AIRWAYS DISORDER187 reports
THROMBOSIS187 reports
CONTUSION186 reports
HYPOTENSION186 reports

Report Outcomes

Out of 13,397 classified reports for MOXIFLOXACIN:

Serious 84.6%Non-Serious 15.4%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female6,501 (54.8%)
Male5,338 (45.0%)
Unknown17 (0.1%)

Reports by Age

Age 65635 reports
Age 72292 reports
Age 44265 reports
Age 66253 reports
Age 50235 reports
Age 70235 reports
Age 52234 reports
Age 71224 reports
Age 60223 reports
Age 58221 reports
Age 67193 reports
Age 69192 reports
Age 64176 reports
Age 47171 reports
Age 53170 reports
Age 68167 reports
Age 59165 reports
Age 63162 reports
Age 57161 reports
Age 55153 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with MOXIFLOXACIN?

This profile reflects 40,887 FDA FAERS reports that mention MOXIFLOXACIN. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for MOXIFLOXACIN?

Frequently reported terms in FAERS include OFF LABEL USE, DRUG INEFFECTIVE, DYSPNOEA, PNEUMONIA, VOMITING, DRUG HYPERSENSITIVITY. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures MOXIFLOXACIN?

Labeling and FAERS entries often list Lifestar Pharma LLC in connection with MOXIFLOXACIN. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.